Pipette adding pink liquid to rows of small test tubes in a laboratory

Australia could produce HSV-2 cure

Published October 21 2013 inNews
stopwatch8 minutes read

Updated in September 2026. This article was first published in October 2013, soon after an Australian HSV-2 vaccine began its first clinical trial. We have added what happened next and the latest research into a cure for Herpes.

Summary:

  • There is still no cure for Herpes. Antiviral medicine can shorten outbreaks, help prevent them and lower the chance of passing the virus on, but the virus stays in the body for life.
  • The Australian vaccine, COR-1, was found to be safe in early trials, but outbreaks fell by a similar amount in people given a placebo, and we could find no later results. Other vaccines and gene-editing treatments are being studied, but none has been approved.
  • If you have a sore or blister, a swab test can confirm whether it is Herpes. The Better2Know Herpes Simplex Type 1 and 2 (IgG) blood test can show whether you have Herpes when you have no symptoms.

In 2013, Australian biotechnology company Coridon began testing a vaccine that it hoped could both prevent and treat Herpes simplex virus type 2 (HSV-2), one of the two viruses that cause genital Herpes.

More than a decade later, people are still asking whether there is a cure for Herpes. In this blog, we look at what happened to the Australian vaccine, what other research is under way and how Herpes is treated today.

Is there a cure for Herpes?

No. There is currently no cure for Herpes. Once you have the Herpes simplex virus (HSV), it stays in your body for life, resting in nerve cells close to where it entered the body. From time to time it can become active again and cause an outbreak of blisters or sores.

Herpes is very common. The World Health Organization (WHO) estimates that in 2020, 3.8 billion people under 50 (64%) had HSV-1, the usual cause of cold sores, and 520 million people aged 15 to 49 (13%) had HSV-2, which mainly causes genital Herpes. Most people with Herpes have no symptoms or do not realise they have it.

Although Herpes cannot be cured, it can be treated. Antiviral medicines can shorten outbreaks and help prevent them, and taking them every day can lower the chance of passing the virus on to a partner. Researchers have been working on vaccines and other treatments for many years, including the Australian vaccine this article first reported on in 2013.

What happened to Australia’s HSV-2 vaccine?

In August 2013, Coridon started a Phase 1 trial of its DNA vaccine, COR-1, in healthy volunteers in Brisbane. The company was founded by Professor Ian Frazer, who helped develop the technology behind the HPV vaccine.

At the time, Professor Frazer was optimistic about the research: “This is the beginning of an exciting period for our herpes vaccine. We have seen very encouraging results from animal studies and we expect pivotal data showing that our vaccine, which incorporates our patented optimisation technology, to produce similar immune responses in the clinic.”

A later Phase 1/2a trial tested COR-1 as a treatment in 44 adults who already had HSV-2. The results, published in 2019, found that the vaccine was safe, and that people who had a booster dose shed less virus than they had before treatment. However, the number of outbreaks fell by a similar amount in people who were given a placebo, so the trial could not show that the vaccine reduced outbreaks.

We could not find any later trial results, and COR-1 has not been approved for use. The research was an important step, but it did not produce the Herpes cure that many people hoped for in 2013.

What other Herpes vaccines and cures are being tested?

Several companies and research groups have tried to develop a Herpes vaccine or cure. So far, none has been approved.

  • GSK: In September 2024, GSK announced that its Herpes treatment vaccine, GSK3943104, did not meet its main goal in a Phase 1/2 trial and would not move on to Phase 3.
  • Moderna: Moderna tested an mRNA treatment vaccine, mRNA-1608, in adults with repeat outbreaks of genital Herpes caused by HSV-2. Early results raised no safety concerns, but in November 2025 the company said the programme would not move on to Phase 3.
  • BioNTech: In December 2022, BioNTech began a Phase 1 trial of BNT163, an mRNA vaccine designed to prevent genital Herpes. BioNTech’s trial listing gives an estimated completion date of October 2026, and no results had been published when we updated this article.
  • Gene editing: In 2024, researchers at Fred Hutch Cancer Center in the US reported that a gene-editing treatment removed 90% or more of the hidden (latent) HSV-1 virus in mice with facial infections, and up to 97% in mice with genital infections. The treatment has not yet been tested in people.

UK guidelines from the British Association for Sexual Health and HIV (BASHH) confirm that no vaccine is currently approved to prevent genital Herpes, although trials are continuing. If you read about a Herpes cure for sale online, be cautious, as no cure has been proven to work. For a wider look at the options, read “Herpes cure: can I get rid of Herpes?”

How is Herpes treated now?

Herpes cannot be cured, but it can be managed well.

  • Antiviral tablets: Medicines such as aciclovir and valaciclovir can stop symptoms getting worse. You need to start them within 5 days of symptoms appearing, and for repeat outbreaks, starting them as soon as symptoms appear may shorten an outbreak by 1 or 2 days.
  • Daily treatment for frequent outbreaks: If you have more than 6 outbreaks a year, you may be offered antiviral tablets to take every day for 6 to 12 months to help prevent them.
  • Pain relief: A painkilling cream, such as 5% lidocaine, can reduce pain when you pee.

Repeat outbreaks are usually milder than the first one, and they tend to happen less often over time. Read more in “Why does my Herpes keep coming back?” and “How long does a Herpes outbreak last?”

Getting diagnosed matters for more than outbreaks. The World Health Organization says HSV-2 makes it around three times more likely that someone will get HIV, and people who have both infections are more likely to pass HIV on. If you test positive for Herpes, our doctors can talk you through your treatment options and how to lower the chance of passing the virus on.

How do you know if you have Herpes?

Herpes symptoms can be mild, and they can look like other conditions, so testing is the only way to know for sure.

If you have symptoms

A swab taken from a blister or sore is the most accurate way to diagnose Herpes, so it is best to test while you have symptoms. The Better2Know Herpes Simplex Type 1 and 2 (Swab) test tells you whether you have Herpes and which type, with results in 5 days. If you are not sure what is causing a sore or bump, the Blemish Screen tests a swab for Herpes 1, Herpes 2, HPV and Syphilis.

If you do not have symptoms

The Herpes Simplex Type 1 and 2 (IgG) blood test looks for antibodies to the virus. You can take it from 28 days after possible exposure, with results in 2 days, at one of our clinics or with a home test kit.

Blood tests are useful, but they have limits. They cannot tell whether an HSV-1 infection is in the mouth or the genitals, and a test taken soon after infection can miss it, so a repeat test 12 weeks after possible exposure may be advised. A positive HSV-2 result at a low level can also be a false positive. Our doctors can explain what your result means. Read more in “How accurate are blood tests for Herpes?”

FAQs

Will there ever be a cure for Herpes?

Researchers are working on vaccines and gene-editing treatments that might one day clear or control the virus, and some early results in animals are promising. But none has been shown to work in people yet, so there is no date for when a cure might be available.

Is there a vaccine for Herpes?

No. There is no approved vaccine to prevent or treat genital Herpes. Several have been tested, including COR-1 from Australia and vaccines from GSK and Moderna, but none has been shown to work well enough to be approved. BioNTech’s vaccine trial is still under way.

Can Herpes go away on its own?

The symptoms of a Herpes outbreak go away, but the virus stays in the body and can cause more outbreaks later. Repeat outbreaks are usually milder than the first and tend to happen less often over time.

Can you pass on Herpes when you have no symptoms?

Yes. Herpes can be passed on even when there are no symptoms, although the risk is highest from the first tingle or itch until any sores have healed. The risk of passing it on without symptoms is higher in the first 6 months after infection, and for many people it falls over time.

Final thoughts

The Australian vaccine did not become the Herpes cure people hoped for in 2013, and there is still no cure today. But Herpes is common, manageable and nothing to be ashamed of. Antiviral treatment can control outbreaks and lower the chance of passing the virus on, and research into vaccines and new treatments continues.

If you think you might have Herpes, get tested. If you have symptoms, book a Herpes Simplex Type 1 and 2 (Swab) test or a Blemish Screen. If you do not have symptoms, the Herpes Simplex Type 1 and 2 (IgG) blood test is available at our clinics and as a home test kit. Our Patient Care Team is available 24/7 on 020 7099 0955.

Don’t leave your sexual health to chance

Most people with Herpes do not know they have it, so they can pass it on without realising. Protect your sexual health by booking a Herpes Simplex Type 1 and 2 (IgG) blood test with Better2Know today.

About this article

Not in the UK? Choose your country from the selector at the top of the page for local tests and prices.

This article originally appeared on 21 October 2013 and was last updated on 29 September 2026.

This article is general information and not a substitute for personal medical advice.

Sources

  1. World Health Organization, Herpes simplex virus, fact sheet, 30 May 2025. https://www.who.int/news-room/fact-sheets/detail/herpes-simplex-virus
  2. NHS, Genital herpes, reviewed 27 June 2023. https://www.nhs.uk/conditions/genital-herpes/
  3. British Association for Sexual Health and HIV, UK national guideline for the management of anogenital herpes, 2024. https://bashh.org/_userfiles/pages/files/pateletal2024britishassociationofsexualhealthandhivuknationalguidelineforthemanagementofanogenital.pdf
  4. Centers for Disease Control and Prevention, Herpes, Sexually Transmitted Infections Treatment Guidelines, 2021. https://www.cdc.gov/std/treatment-guidelines/herpes.htm
  5. Medical Daily, Herpes vaccine enters early-stage clinical trial in Australia; scientists hope for HSV-2 cure, 17 July 2013. https://www.medicaldaily.com/herpes-vaccine-enters-early-stage-clinical-trial-australia-scientists-hope-hsv-2-cure-247759
  6. Australian New Zealand Clinical Trials Registry, ACTRN12613000831785, registered 29 July 2013. https://anzctr.org.au/ACTRN12613000831785.aspx
  7. PLOS ONE, Immune responses to a HSV-2 polynucleotide immunotherapy COR-1 in HSV-2 positive subjects: a randomized double blinded phase I/IIa trial, 17 December 2019. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0226320
  8. GSK, GSK provides update on phase I/II therapeutic herpes simplex virus (HSV) vaccine trial, 11 September 2024. https://gsk.com/media/11551/press-release-gsk-provides-update-on-phase-ii-therapeutic-herpes-simplex-virus.pdf
  9. Moderna, Moderna Analyst Day highlights pipeline progress and business strategy updates, 20 November 2025. https://www.sec.gov/Archives/edgar/data/1682852/000162828025053318/exhibit9912025analystday.htm
  10. BioNTech, BioNTech starts Phase 1 clinical trial for prophylactic herpes simplex virus-2 vaccine candidate BNT163, 21 December 2022. https://www.biontech.com/us/en/home/mediaroom/news/press-releases/2022/12/biontech-starts-phase-1-clinical-trial-prophylactic-herpes.html
  11. BioNTech, BNT163-01 clinical trial listing (NCT05432583). https://clinicaltrials.biontech.com/trials/BNT163-01
  12. Wald A, Comeaux CA, Embry A, et al. mRNA-1608, an mRNA-based therapeutic genital herpes vaccine candidate: interim safety, immunogenicity and clinical endpoint results from a phase 1/2, randomized, observer-blind, controlled, dose-ranging trial. Open Forum Infectious Diseases, 2026;13(Suppl 1):ofaf695.206. https://academic.oup.com/ofid/article/13/Supplement_1/ofaf695.206/8420100
  13. National Health and Medical Research Council, Gardasil HPV vaccine, impact case study. https://www.nhmrc.gov.au/about-us/resources/impact-case-studies/gardasilr-hpv-vaccine
  14. Nature Communications, Gene editing for latent herpes simplex virus infection reduces viral load and shedding in vivo, 13 May 2024. https://www.nature.com/articles/s41467-024-47940-y
  15. Fred Hutch Cancer Center, Herpes cure with gene editing makes progress in laboratory studies, 13 May 2024. https://www.fredhutch.org/en/news/releases/2024/05/herpes-cure-with-gene-editing-makes-progress-in-laboratory-studi.html
ABOUT THE AUTHOR

Mike has been delivering world class Sexually Transmitted Infections testing services to Better2Know patients around the world for over ten years. He has written extensively on the subject, including numerous blogs for Better2Know which are designed to demystify the complex intricacies of sexual health testing. Mike wants to help his readers understand the risks they take in their daily sexual lives and provide the information they need when choosing an STI or STD test in a clear, concise and understandable way. Mike is particularly interested in writing about viral STIs like HIV and Hepatitis, as these infections can have a devastating impact on people's lives if they are not diagnosed quickly. Only through being well informed can you best care for your health, and Mike is passionate about sharing his knowledge and experience to help you and all his readers lead a happier, healthier life.